Signals, Powered By EquityPandit
Glenmark Pharmaceuticals has got the US health regulator’s final approval for a generic version of anti-bacterial drug Zyvox.
The company said in a statement that “Glenmark Pharmaceuticals Inc, USA, has been granted final approval by the US Food & Drug Administration (USFDA) for the Linezolid tablets, 600 mg.”
It further said that the product is the therapeutic equivalent of Zyvox tablets, 600 mg of Pharmacia and Upjohn Company, a subsidiary of Pfizer.
